Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study

A live attenuated zoster vaccine was licensed in the United States in 2006 for prevention of shingles in persons aged 60 years or older; the indication was extended in 2011 to cover those aged 50–59 years. We assessed vaccine effectiveness (VE) against shingles for 8 years after immunization at Kais...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Epidemiol
Glavni autori: Baxter, Roger, Bartlett, Joan, Fireman, Bruce, Marks, Morgan, Hansen, John, Lewis, Edwin, Aukes, Laurie, Chen, Yong, Klein, Nicola P, Saddier, Patricia
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Practice of Epidemiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018833/
https://ncbi.nlm.nih.gov/pubmed/29309521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwx245
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items